Guidelines were developed by the American Epilepsy Society (AES) and the American Academy of Neurology (AAN) to help health care professionals understand published research findings on the use of the newer seizure medicines. These guidelines summarize the use of newer seizure medicines for people newly diagnosed with seizures and for those with refractory seizures (seizures that have not been successfully controlled by medication). A third guideline summarizes information on available treatments for refractory epilepsy. These guidelines do not address the issue of the older seizure medicines.
See a commentary: New guidelines should improve treatment but point out paradox.
Topic Editor: Steven C. Schachter, MD and Patricia O. Shafer, RN, MN.
Last Reviewed: 11/7/07
Welcome to the Wiki. This space is created for epilepsy.com members to share their own experiences and expertise to help refine and expand the discussion around important topics.
No members have yet contributed to this topic. If you are not yet an epilepsy.com member, register today to get started on this Wiki topic and the many other advantages of being a member. If you are a member and wish to be the first to edit this Wiki topic, please make sure to login, then click on the orange "Start Wiki" button at the top of this page. Or, learn more about Wikis.